Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Sunshine Biopharma (SBFMW) Debt Ratio (2017 - 2021)

Historic Debt Ratio for Sunshine Biopharma (SBFMW) over the last 5 years, with Q4 2021 value amounting to 0.86.

  • Sunshine Biopharma's Debt Ratio fell 498.22% to 0.86 in Q4 2021 from the same period last year, while for Dec 2021 it was 0.86, marking a year-over-year decrease of 498.22%. This contributed to the annual value of 0.86 for FY2021, which is 498.22% down from last year.
  • Per Sunshine Biopharma's latest filing, its Debt Ratio stood at 0.86 for Q4 2021, which was down 498.22% from 1.28 recorded in Q3 2021.
  • Sunshine Biopharma's 5-year Debt Ratio high stood at 1.28 for Q3 2021, and its period low was 0.19 during Q3 2019.
  • For the 5-year period, Sunshine Biopharma's Debt Ratio averaged around 0.59, with its median value being 0.31 (2017).
  • Per our database at Business Quant, Sunshine Biopharma's Debt Ratio crashed by 3350.34% in 2019 and then soared by 14764.36% in 2021.
  • Quarter analysis of 5 years shows Sunshine Biopharma's Debt Ratio stood at 0.31 in 2017, then fell by 12.46% to 0.27 in 2018, then tumbled by 30.55% to 0.19 in 2019, then surged by 382.31% to 0.91 in 2020, then decreased by 4.98% to 0.86 in 2021.
  • Its last three reported values are 0.86 in Q4 2021, 1.28 for Q3 2021, and 1.13 during Q2 2021.